[The results of acute drug testing and a course of treatment with activators of the GABA-ergic stress-limiting system in cardiac arrhythmia patients].
V V
VV
Skibitskiĭ
S G
SG
Kanorskiĭ
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000502:physiology; D013312:Stress, Physiological / Q000503:physiopathology*; D014700:Verapamil / Q000008:administration & dosage
D014151:Anti-Anxiety Agents; D000889:Anti-Arrhythmia Agents; D001570:Benzodiazepinones; D011963:Receptors, GABA-A; D001569:Benzodiazepines; C017928:phenazepam; D014700:Verapamil; C077010:gidazepam